National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings, 67453-67454 [2024-18557]

Download as PDF Federal Register / Vol. 89, No. 161 / Tuesday, August 20, 2024 / Notices khammond on DSKJM1Z7X2PROD with NOTICES need special assistance or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https://videocast. nih.gov/. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Advisory Council. Date: September 19, 2024. Closed: 9:00 a.m. to 10:30 a.m. Agenda: To review and evaluate grant applications. Place: National Center for Advancing Translational Sciences, National Institutes of Health, NCI Shady Grove, Seminar 110, 9609 Medical Center Drive, Rockville, MD 20850 (In Person and Virtual Meeting). Open: 11:15 a.m. to 5:30 p.m. Agenda: Report from the Center Director, Special Topic Presentation, Program Updates, Clearance of Concepts. Place: National Center for Advancing Translational Sciences, National Institutes of Health, NCI Shady Grove, Seminar 110, 9609 Medical Center Drive, Rockville, MD 20850 In Person and Virtual Meeting. Contact Person: Anna L. Ramsey-Ewing, Ph.D., Executive Secretary, National Center for Advancing Translational Sciences, National Institutes of Health, 9609 Medical Center Drive, Room 1E454, Rockville, Maryland 20850, anna.ramseyewing@ nih.gov, (301) 435–0809. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice no later than 15 days after the meeting at NCATSCouncilInput@ mail.nih.gov. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// ncats.nih.gov/advisory/council, where an VerDate Sep<11>2014 17:24 Aug 19, 2024 Jkt 262001 agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B—Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS) Dated: August 14, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18560 Filed 8–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of a meeting of the National Cancer Institute Council of Research Advocates. The meeting will be held as a hybrid meeting and will be open to the public as indicated below. Individuals who plan to view the virtual meeting and need special assistance or other reasonable accommodations to view the meeting, should notify the Contact Person listed below in advance of the meeting. The meeting can be accessed from the NIH Videocast at the following link: https://videocast.nih.gov/. Name of Committee: National Cancer Institute Council of Research Advocates (NCRA). Date: September 18, 2024. Time: 10:00 a.m. to 3:00 p.m. Agenda: Welcome and Chairwoman’s Remarks, NCI Director’s Update, NCI Updates, and Legislative Update. Place: National Institutes of Health, Porter Neuroscience Research Center, Building 35A, Room 640, 35 Convent Drive, Bethesda, MD 20892 (In Person and Virtual Meeting). Contact Person: Amy Williams, Director, NCI Office of Advocacy Relations, National Cancer Institute, NIH, 31 Center Drive, Building 31, Room 10A28, Bethesda, MD 20892, (301) 496–9723, williaam@ mail.nih.gov. Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. In the interest of security, NIH has procedures at https://www.nih.gov/aboutnih/visitor-information/campus-accesssecurity for entrance into on-campus and offcampus facilities. All visitor vehicles, including taxicabs, hotel, and airport shuttles PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 67453 will be inspected before being allowed on campus. Visitors attending a meeting on campus or at an off-campus federal facility will be asked to show one form of identification (for example, a governmentissued photo ID, driver’s license, or passport) and to state the purpose of their visit. Information is also available on the Institute’s/Center’s home page: https:// deainfo.nci.nih.gov/advisory/ncra/ncra.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: August 14, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18559 Filed 8–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Special Emphasis Panel; Review of Ruth L. Kirschstein Institutional National Research Service Award. Date: September 9, 2024. Time: 1:00 p.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Beata Buzas, Ph.D., Scientific Review Officer, Extramural Project E:\FR\FM\20AUN1.SGM 20AUN1 khammond on DSKJM1Z7X2PROD with NOTICES 67454 Federal Register / Vol. 89, No. 161 / Tuesday, August 20, 2024 / Notices Review Branch, Office of Extramural Activities, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2116, MSC 6902, Bethesda, MD 20817, (301) 443–0800, bbuzas@mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Clinical, Treatment and Health Services Research Study Section. Date: October 8, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, Extramural Project Review Branch, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2109, MSC 6902, Bethesda, MD 20817, (301) 443–8599, espinozala@ mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Epidemiology, Prevention and Behavior Research Study Section. Date: October 22, 2024. Time: 9:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892, (In-Person and Virtual). Contact Person: Anna Ghambaryan, M.D., Ph.D., Scientific Review Officer, Extramural Project Review Branch, Office of Extramural Activities, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2120, MSC 6902, Bethesda, MD 20892, 301–443–4032, anna.ghambaryan@ nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Neuroscience and Behavior Study Section. Date: October 24, 2024. Time: 10:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Beata Buzas, Ph.D., Scientific Review Officer, Extramural Project Review Branch, Office of Extramural Activities, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2116, MSC 6902, Bethesda, MD 20892, 301–443–0800, bbuzas@mail.nih.gov. Name of Committee: National Institute on Alcohol Abuse and Alcoholism Initial Review Group; Biomedical Research Study Section. Date: October 29, 2024. Time: 9:00 a.m. to 3:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Health, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 20892, (In-Person and Virtual). VerDate Sep<11>2014 17:24 Aug 19, 2024 Jkt 262001 Contact Person: Anna Ghambaryan, M.D., Ph.D., Scientific Review Officer, Extramural Project Review Branch, Office of Extramural Activities, National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2120, MSC 6902, Bethesda, MD 20892, (301) 443–4032, anna.ghambaryan@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.273, Alcohol Research Programs, National Institutes of Health, HHS) Dated: August 14, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18557 Filed 8–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR 22– 104: Fogarty NCD–LIFESPAN Panel. Date: September 10, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Jeanne M. McCaffery, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594–3854, jeanne.mccaffery@ nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–22– 079: High-End Instrumentation (HEI) Grant Program. Date: September 24, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Krystyna H. Szymczyk, Ph.D., Scientific Review Officer, Center for PO 00000 Frm 00048 Fmt 4703 Sfmt 4703 Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 480–4198, szymczykk@ csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR Panel: Biomedical Imaging and Metabolism Instrumentation S10 Grant Programs. Date: September 25, 2024. Time: 9:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Steven Anthony Ripp, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive Bethesda, MD 20892, (301) 594–3010, steven.ripp@nih.gov. Name of Committee: Cell Biology Integrated Review Group; Cellular Signaling and Regulatory Systems Study Section. Date: September 26–27, 2024. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). Contact Person: David Balasundaram, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5189, MSC 7840, Bethesda, MD 20892, 301–435– 1022, balasundaramd@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: August 14, 2024. David W. Freeman, Supervisory Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–18563 Filed 8–19–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract E:\FR\FM\20AUN1.SGM 20AUN1

Agencies

[Federal Register Volume 89, Number 161 (Tuesday, August 20, 2024)]
[Notices]
[Pages 67453-67454]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-18557]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel; Review of Ruth L. Kirschstein 
Institutional National Research Service Award.
    Date: September 9, 2024.
    Time: 1:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892, (Virtual Meeting).
    Contact Person: Beata Buzas, Ph.D., Scientific Review Officer, 
Extramural Project

[[Page 67454]]

Review Branch, Office of Extramural Activities, National Institute 
on Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Room 2116, 
MSC 6902, Bethesda, MD 20817, (301) 443-0800, [email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group; Clinical, Treatment and Health 
Services Research Study Section.
    Date: October 8, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892, (Virtual Meeting).
    Contact Person: Luis Espinoza, Ph.D., Scientific Review Officer, 
Extramural Project Review Branch, National Institute on Alcohol 
Abuse and Alcoholism, 6700B Rockledge Drive, Room 2109, MSC 6902, 
Bethesda, MD 20817, (301) 443-8599, [email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group; Epidemiology, Prevention and 
Behavior Research Study Section.
    Date: October 22, 2024.
    Time: 9:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892, (In-Person and Virtual).
    Contact Person: Anna Ghambaryan, M.D., Ph.D., Scientific Review 
Officer, Extramural Project Review Branch, Office of Extramural 
Activities, National Institute on Alcohol Abuse and Alcoholism, 
6700B Rockledge Drive, Room 2120, MSC 6902, Bethesda, MD 20892, 301-
443-4032, [email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group; Neuroscience and Behavior Study 
Section.
    Date: October 24, 2024.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892, (Virtual Meeting).
    Contact Person: Beata Buzas, Ph.D., Scientific Review Officer, 
Extramural Project Review Branch, Office of Extramural Activities, 
National Institute on Alcohol Abuse and Alcoholism, 6700B Rockledge 
Drive, Room 2116, MSC 6902, Bethesda, MD 20892, 301-443-0800, 
[email protected].

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Initial Review Group; Biomedical Research Study Section.
    Date: October 29, 2024.
    Time: 9:00 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institute of Health, National Institute on 
Alcohol Abuse and Alcoholism, 6700B Rockledge Drive, Bethesda, MD 
20892, (In-Person and Virtual).
    Contact Person: Anna Ghambaryan, M.D., Ph.D., Scientific Review 
Officer, Extramural Project Review Branch, Office of Extramural 
Activities, National Institute on Alcohol Abuse and Alcoholism, 
6700B Rockledge Drive, Room 2120, MSC 6902, Bethesda, MD 20892, 
(301) 443-4032, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.273, 
Alcohol Research Programs, National Institutes of Health, HHS)

    Dated: August 14, 2024.
David W. Freeman,
Supervisory Program Analyst, Office of Federal Advisory Committee 
Policy.
[FR Doc. 2024-18557 Filed 8-19-24; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.